Diadema Partners »

Eupraxia Pharmaceuticals shares owned by Diadema Partners

Quarter-by-quarter ownership of Eupraxia Pharmaceuticals (EPRX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Eupraxia Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eupraxia Pharmaceuticals held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eupraxia Pharmaceuticals by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $290k 40k 7.24

More positions owned by Diadema Partners

United Therapeutics Corporation Put Option (UTHR)
Vertex Pharmaceuticals Incorporated (VRTX)
Viking Therapeutics (VKTX)
Capricor Therapeutics Com New Call Option (CAPR)
Abivax Sa Sponsored Ads (ABVX)
Liquidia Corporation Com New Call Option (LQDA)
Revolution Medicines (RVMD)
Apogee Therapeutics Call Option (APGE)
Bridgebio Pharma Note 1.750% 3/0
Incyte Corporation Put Option (INCY)
Kodiak Sciences Put Option (KOD)
Cytokinetics Com New Call Option (CYTK)
Johnson & Johnson (JNJ)
Cogent Biosciences (COGT)
Merck & Co Put Option (MRK)

View all positions for Diadema Partners

Top funds holding Eupraxia Pharmaceuticals

Beutel, Goodman & Company
Affinity Asset Advisors
Vivo Capital
Balyasny Asset Management
Scotia Capital
Ikarian Capital
Dr. Jeffrey R. Jay, M.D.
Point72 Asset Management
UBS Group
Redmile Group
Rubric Capital Management
Squadron Capital Management
Ally Bridge Group
Ameriprise Financial
Partner Fund Management

View all funds holding Eupraxia Pharmaceuticals